Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis.

ABSTRACT:

Background

The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and coronavirus disease 2019 (COVID-19), has caused more than 3.9 million cases worldwide. Currently, there is great interest to assess venous thrombosis prevalence, diagnosis, prevention, and management in patients with COVID-19.

Objectives

To determine the prevalence of venous thromboembolism (VTE) in critically ill patients with COVID-19, using lower limbs venous ultrasonography screening.

Methods

Beginning March 8, we enrolled 25 patients who were admitted to the intensive care unit (ICU) with confirmed SARS-CoV-2 infections. The presence of lower extremity deep vein thrombosis (DVT) was systematically assessed by ultrasonography between day 5 and 10 after admission. T

SUBMITTER: Longchamp A 

PROVIDER: S-EPMC7272794 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature